Murine asialo GM1+CD8+ T cells as novel interleukin-12-responsive killer T cell precursors

Japanese Journal of Cancer Research

Volumn 87, Issue 5, 1996, Pages 429-432

  Lee, Ushaku ^a,b   Santa, Kazuki ^a   Habu, Sonoko ^a   Nishimura, Takashi ^a  

^a TOKAI UNIVERSITY   (Japan)

^b KANAGAWA DENTAL COLLEGE   (Japan)

Author keywords

Asialo GM1; CD8+ T cell; IFN ; IL 12; Killer T cell precursor

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GANGLIOTETRAOSYLCERAMIDE; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL CELL; ARTICLE; CYTOLYSIS; FEMALE; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROLYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0030013438     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb00241.x     Document Type: Article

References (17)

1. Kobayashi, M., Fitz, L., Ryan, M., Hewich, R. M., Clark, S. C., Loudon, S., Sherman, F., Perussia, B. and Trinchieri, G. Identification and characterization of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J. Exp. Med., 170, 827-845 (1989).
2. Gately, M. K., Warrier, R. R., Honasoge, S., Carvajal, D. M., Faherty, D. A., Connaughton, S. E., Anderson, T. D., Sarminento, U., Hubbard, B. R. and Murphy, M. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int. Immunol., 6, 157-167 (1993).
3. H1 cells. Immunol. Today, 14, 335-337 (1993).
4. Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F. and Gately, M. K. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med., 178, 1223-1230 (1993).
5. Zou, J.-P., Yamamoto, N., Fujii, T., Takenaka, H., Kobayashi, M., Herrmann, S. H., Wolf, S. F., Fujiwara, H. and Hamaoka, T. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-γ production by anti-tumor T cells. Int. Immunol., 7, 1135-1145 (1995).
6. Nishimura, T., Watanabe, K., Lee, U., Yahata, T., Ando, K., Kimura, M., Hiroyama, Y., Kobayashi, M., Herrmann, S. H. and Habu, S. Systemic in vivo antitumor activity of interleukin-12 against both transplantable and primary tumor. Immunol. Lett. (1995) in press.
7. + T cells through IL-12 produced by Listeria-induced macrophages. Science, 260, 547-549 (1993).
8. Chua, A. O., Wilkinson, V. L., Presky, D. H. and Gubler, U. Cloning of a mouse IL-12 receptor-β component. J. Immunol., 155, 4286-4294 (1995).
9. Nishimura, T., Burakoff, S. J. and Herrmann, S. H. Protein kinase C required for cytotoxic T lymphocyte triggering. J. Immunol., 130, 2888-2891 (1987).
10. Habu, S., Fukui, H., Shimamura, K., Kasai, M., Nagai, Y., Okumura, K. and Tamaoki, N. In vivo effect of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J. Immunol., 127, 34-38 (1981).
11. Ting, C.-C., Hargrove, M. E., Wunderlich, J. and Loh, N.-N. Differential expression of asialo GM1 on alloactivated cytotoxic T lymphocytes and lymphokine-activated killer cells. Cell. Immunol., 104, 115-125 (1987).
12. Bertagnolli, M. M., Lin, B.-Y., Young, D. and Herrmann, S. H. IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J. Immunol., 149, 3778-3783 (1993).
13. Trinchieri, G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood, 84, 4008-4027 (1994).
14. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today, 16, 34-38 (1995).
15. Tanaka, Y., Takahashi, A., Watanabe, K., Takayama, K., Yahata, T., Habu, S. and Nishimura, T. A pivotal role of interleukin-12 in Th1-dependent mouse liver injury. Int. Immunol., 8, (1995) in press.
16. + T cells secreting Th1 or Th2 cytokines. Immunity, 2, 271-279 (1995).
17. + thymocytesm vitro. J. Immunol., 145, 4012-4017 (1990).